Abstract:Tanshinol has desirable antianginal and pharmacokinetic properties and is a key compound of Salvia miltiorrhiza roots (Danshen). It is extensively cleared by renal excretion. This study was designed to elucidate the mechanism underlying renal tubular secretion of tanshinol and to compare different ways to manipulate systemic exposure to the compound. Cellular uptake of tanshinol was mediated by human organic anion transporter 1 (OAT1) (Km, 121 μM), OAT2 (859 μM), OAT3 (1888 μM), and OAT4 (1880 μM) and rat Oat1 (117 µM), Oat2 (1207 μM), and Oat3 (1498 μM). Other renal transporters (human organic anion-transporting polypeptide 4C1 [OATP4C1], organic cation transporter 2 [OCT2], carnitine/organic cation transporter 1 [OCTN1], multidrug and toxin extrusion protein 1 [MATE1], MATE2-K, multidrug resistance-associated protein 2 [MRP2], MRP4, and breast cancer resistance protein [BCRP], and rat Oct1, Oct2, Octn1, Octn2, Mate1, Mrp2, Mrp4, and Bcrp) showed either ambiguous ability to transport tanshinol or no transport activity. Rats may be a useful model, to investigate the contribution of the renal transporters on the systemic and renal exposure to tanshinol. Probenecid-induced impairment of tubular secretion resulted in a 3- to 5-fold increase in the rat plasma area under the plasma concentration-time curve from 0 to infinity (AUC0-∞) of tanshinol. Tanshinol exhibited linear plasma pharmacokinetic properties over a large intravenous dose range (2-200 mg/kg) in rats. The dosage adjustment could result in increases in the plasma AUC0-∞ of tanshinol of about 100-fold. Tanshinol exhibited very little dose-related nephrotoxicity. In summary, renal tubular secretion of tanshinol consists of uptake from blood, primarily by OAT1/Oat1, and the subsequent luminal efflux into urine mainly by passive diffusion. Dosage adjustment appears to be an efficient and safe way to manipulate systemic exposure to tanshinol. Tanshinol shows low propensity to cause renal transporter-mediated herb-drug interactions.

Metabolic kinetics of tanshinone Ⅱ A in rat liver microsomal enzyme

Kinetics of cytochrome P450 enzymes for metabolism of sodium tanshinone IIA sulfonate in vitro.

Inhibitory Effect of Tanshinones on Rat CYP3A2 and CYP2C11 Activity and Its Structure-Activity Relationship.

Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases.

Effects of Matrine and Oxymatrine on Catalytic Activity of Cytochrome P450s in Rats.

In Vitro Metabolism of E2, G2: Novel Bile Acid-Coupling Camptothecin Analogues, in Rat Liver Microsomes

Pharmacokinetic interaction studies of tanshinones with tolbutamide, a model CYP2C11 probe substrate, using liver microsomes, primary hepatocytes and in vivo in the rat

Sodium Tanshinone IIA Sulfonate and Its Interactions with Human CYP450s

Characterization of metabolites of tanshinone IIA in rats by liquid chromatography/tandem mass spectrometry.

Effects of Cryptotanshinone on Cytochrome P450 Isoforms in Rat Liver Microsomes

Hydroxylation of Tanshinone IIa in Human Liver Microsomes is Specifically Catalysed by Cytochrome P4502A6.

Effects of the Coexisting Diterpenoid Tanshinones on the Pharmacokinetics of Cryptotanshinone and Tanshinone IIA in Rat.

Effect of Sodium Tanshinone II A Sulfonate on the Activity of CYP1A2 in Healthy Volunteers

Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line.

Enzyme Kinetics of Genistein Metabolism in Rat Liver Microsomes

Identification of tanshinone IIA metabolites in rat liver microsomes by liquid chromatography-tandem mass spectrometry.

Role of ATP-binding cassette drug transporters in the intestinal absorption of tanshinone IIB, one of the major active diterpenoids from the root of Salvia miltiorrhiza.

Studies on the metabolism and effect on the CYP450 of CH330331 in rat liver microsomes

Activation of CYP3A-mediated Testosterone 6Β-Hydroxylation by Tanshinone IIA and Midazolam 1-Hydroxylation by Cryptotanshinone in Human Liver Microsomes.

Methylation and Its Role in the Disposition of Tanshinol, a Cardiovascular Carboxylic Catechol from Salvia Miltiorrhiza Roots (Danshen)

Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions.